IRONWOOD PHARMACEUTICALS, INC. Increase (Decrease) in Inventories
IRONWOOD PHARMACEUTICALS, INC. (IRWD) reported Increase (Decrease) in Inventories of -$648.00 thousand for the 12-month period ending 2020-12-31, per its 10-K filed 2023-02-16.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInInventories · last filed 2023-02-16
- IRONWOOD PHARMACEUTICALS, INC. increase (decrease) in inventories for the quarter ending 2020-12-31 was $0.00.
- IRONWOOD PHARMACEUTICALS, INC. increase (decrease) in inventories for the quarter ending 2020-09-30 was $0.00, a 100.00% decline year-over-year.
- IRONWOOD PHARMACEUTICALS, INC. increase (decrease) in inventories for the quarter ending 2019-09-30 was $451.00K.
- IRONWOOD PHARMACEUTICALS, INC. increase (decrease) in inventories for the quarter ending 2019-06-30 was $483.00K, a 115.63% increase year-over-year.
- IRONWOOD PHARMACEUTICALS, INC. increase (decrease) in inventories for fiscal 2020 was -$648.00K.
- IRONWOOD PHARMACEUTICALS, INC. increase (decrease) in inventories for fiscal 2018 was $806.00K.
- IRONWOOD PHARMACEUTICALS, INC. increase (decrease) in inventories for fiscal 2017 was -$346.00K.
- IRONWOOD PHARMACEUTICALS, INC. increase (decrease) in inventories for fiscal 2014 was $3.08M, a 74.17% decline from fiscal 2013.
| Period end | Increase (Decrease) in Inventories 3 month | Increase (Decrease) in Inventories 6 month | Increase (Decrease) in Inventories 9 month | Increase (Decrease) in Inventories 12 month |
|---|---|---|---|---|
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-16 | $0.00 derived: sum of 2 quarters · filed 2023-02-16 | -$648.00K 10-K · filed 2023-02-16 | |
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | -$648.00K 10-Q · filed 2021-11-04 | ||
| 2020-06-30 | -$648.00K 10-Q · filed 2021-08-05 | |||
| 2019-09-30 | $451.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | $934.00K derived: sum of 2 quarters · filed 2020-11-05 | $1.09M 10-Q · filed 2020-11-05 | $1.18M derived: sum of 4 quarters · filed 2021-02-17 |
| 2019-06-30 | $483.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06 | $635.00K 10-Q · filed 2020-08-06 | $728.00K derived: sum of 3 quarters · filed 2021-02-17 | $449.00K derived: sum of 4 quarters · filed 2021-02-17 |
| 2019-03-31 | $152.00K 10-Q · filed 2020-05-06 | $245.00K derived: sum of 2 quarters · filed 2021-02-17 | -$34.00K derived: sum of 3 quarters · filed 2021-02-17 | $190.00K derived: sum of 4 quarters · filed 2021-02-17 |
| 2018-12-31 | $93.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-17 | -$186.00K derived: sum of 2 quarters · filed 2021-02-17 | $38.00K derived: sum of 3 quarters · filed 2021-02-17 | $806.00K 10-K · filed 2021-02-17 |
| 2018-09-30 | -$279.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-31 | -$55.00K derived: sum of 2 quarters · filed 2019-10-31 | $713.00K 10-Q · filed 2019-10-31 | $1.45M derived: sum of 4 quarters · filed 2020-02-13 |
| 2018-06-30 | $224.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-07-30 | $992.00K 10-Q · filed 2019-07-30 | $1.73M derived: sum of 3 quarters · filed 2020-02-13 | $1.73M derived: sum of 4 quarters · filed 2020-02-13 |
| 2018-03-31 | $768.00K 10-Q · filed 2019-05-02 | $1.50M derived: sum of 2 quarters · filed 2020-02-13 | $1.50M derived: sum of 3 quarters · filed 2020-02-13 | $493.00K derived: sum of 4 quarters · filed 2020-02-13 |
| 2017-12-31 | $735.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-13 | $735.00K derived: sum of 2 quarters · filed 2020-02-13 | -$275.00K derived: sum of 3 quarters · filed 2020-02-13 | -$346.00K 10-K · filed 2020-02-13 |
| 2017-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-06 | -$1.01M derived: sum of 2 quarters · filed 2018-11-06 | -$1.08M 10-Q · filed 2018-11-06 | |
| 2017-06-30 | -$1.01M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-06 | -$1.08M 10-Q · filed 2018-08-06 | ||
| 2017-03-31 | -$71.00K 10-Q · filed 2018-05-04 | |||
| 2015-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-07 | -$4.00K 10-Q · filed 2015-08-07 | $3.30M derived: sum of 3 quarters · filed 2017-02-22 | $3.35M derived: sum of 4 quarters · filed 2017-02-22 |
| 2015-03-31 | -$4.00K 10-Q · filed 2016-05-10 | $3.30M derived: sum of 2 quarters · filed 2017-02-22 | $3.35M derived: sum of 3 quarters · filed 2017-02-22 | $1.81M derived: sum of 4 quarters · filed 2017-02-22 |
| 2014-12-31 | $3.30M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-22 | $3.35M derived: sum of 2 quarters · filed 2017-02-22 | $1.81M derived: sum of 3 quarters · filed 2017-02-22 | $3.08M 10-K · filed 2017-02-22 |
| 2014-09-30 | $48.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-05 | -$1.49M derived: sum of 2 quarters · filed 2015-11-05 | -$224.00K 10-Q · filed 2015-11-05 | $1.34M derived: sum of 4 quarters · filed 2016-02-19 |
| 2014-06-30 | -$1.54M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-07 | -$272.00K 10-Q · filed 2015-08-07 | $1.30M derived: sum of 3 quarters · filed 2016-02-19 | $1.45M derived: sum of 4 quarters · filed 2016-02-19 |
| 2014-03-31 | $1.26M 10-Q · filed 2015-05-06 | $2.83M derived: sum of 2 quarters · filed 2016-02-19 | $2.98M derived: sum of 3 quarters · filed 2016-02-19 | $174.00K derived: sum of 4 quarters · filed 2016-02-19 |
| 2013-12-31 | $1.57M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-19 | $1.72M derived: sum of 2 quarters · filed 2016-02-19 | -$1.09M derived: sum of 3 quarters · filed 2016-02-19 | $11.91M 10-K · filed 2016-02-19 |
| 2013-09-30 | $150.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-05 | -$2.66M derived: sum of 2 quarters · filed 2014-11-05 | $10.35M 10-Q · filed 2014-11-05 | $16.08M derived: sum of 4 quarters · filed 2015-02-18 |
| 2013-06-30 | -$2.81M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-05 | $10.20M 10-Q · filed 2014-08-05 | $15.93M derived: sum of 3 quarters · filed 2015-02-18 | |
| 2013-03-31 | $13.01M 10-Q · filed 2014-04-29 | $18.74M derived: sum of 2 quarters · filed 2015-02-18 | ||
| 2012-12-31 | $5.73M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-18 | $6.70M 10-K · filed 2015-02-18 | ||
| 2012-09-30 | $965.00K 10-Q · filed 2013-10-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Nuvectis Pharma, Inc. (NVCT) | United States | $0.705B | -17.53 |
| Climb Bio, Inc. (CLYM) | United States | $0.683B | -13.03 |
| Verastem, Inc. (VSTM) | United States | $0.706B | -1.71 |
| ZEVRA THERAPEUTICS, INC. (ZVRA) | United States | $0.668B | 14.61 |
| COLLEGIUM PHARMACEUTICAL, INC (COLL) | United States | $0.737B | 24.57 |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| Faeth Therapeutics, Inc. (FTH) | United States | $0.750B | |
| Shattuck Labs, Inc. (STTK) | United States | $0.634B | -13.30 |
| Neurogene Inc. (NGNE) | $0.625B | -4.46 | |
| Design Therapeutics, Inc. (DSGN) | United States | $0.766B | -12.78 |